Recent Pathway Changes

From WikiPathways

Jump to: navigation, search

Showing below up to 50 results starting with #101.

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)

  1. (diff) . . Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC): 11 November 2024 by Eweitz ‎(Add CHEBI identifiers, refine labels)
  2. (diff) . . Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC): 11 November 2024 by Eweitz ‎(Connect nodes in mevalonate pathway)
  3. (diff) . . Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC): 11 November 2024 by Eweitz ‎(Add interactions, groups, complexes)
  4. (diff) . . Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC): 11 November 2024 by Eweitz ‎(Organize nodes)
  5. (diff) . . Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC): 11 November 2024 by Eweitz ‎(New pathway)
  6. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Add ChEBI identifiers for TKIs)
  7. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Add PharmGKB identifiers)
  8. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Ontology Term : 'glial cell' added !)
  9. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Add RTK pathways)
  10. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Modified description)
  11. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Ontology Term : 'glioblastoma' added !)
  12. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Modified description)
  13. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Add literature reference)
  14. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 11 November 2024 by Eweitz ‎(Add more interactions, organelle, pathway containers)
  15. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 10 November 2024 by Eweitz ‎(Add more interactions)
  16. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 10 November 2024 by Eweitz ‎(Add interactions, labels)
  17. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 10 November 2024 by Eweitz ‎(Add more metabolites, identifiers)
  18. (diff) . . Homo sapiens:Tyrosine kinase inhibitors in glioblastoma: 10 November 2024 by Eweitz ‎(New pathway)
  19. (diff) . . Homo sapiens:Hallmark of cancer: non-mutational epigenetic reprogramming: 09 November 2024 by Egonw ‎(Removed template comments)
  20. (diff) . . Homo sapiens:Hallmark of cancer: sustaining proliferative signaling: 09 November 2024 by Egonw ‎(Removed template comments)
  21. (diff) . . Homo sapiens:Regulation of cytotoxic T cell responses by Malat1 - miR-15/16 circuit : 09 November 2024 by Egonw ‎(Probably accession numbers)
  22. (diff) . . Homo sapiens:Transcriptional regulation of memory B cell differentiation: 09 November 2024 by Egonw ‎(Moved the question mark identifier to a comment)
  23. (diff) . . Saccharomyces cerevisiae:De novo biosynthesis of pyrimidine ribonucleotides: 09 November 2024 by Egonw ‎(Normalized a EC identifier)
  24. (diff) . . Homo sapiens:Omega-3-fatty acids in senescence: 09 November 2024 by Egonw ‎(Normalized two Rhea identifiers)
  25. (diff) . . Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4: 09 November 2024 by Eweitz ‎(Fix PathVisio / Kaavio discrepancy with "double" line style)
  26. (diff) . . Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4: 09 November 2024 by Eweitz ‎(Expand MAPK gene family)
  27. (diff) . . Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4: 09 November 2024 by Eweitz ‎(Refine NFKB modeling as complex, not merely group)
  28. (diff) . . Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4: 09 November 2024 by Eweitz ‎(Use gene symbol)
  29. (diff) . . Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4: 09 November 2024 by Eweitz ‎(Expand NFI gene family)
  30. (diff) . . Homo sapiens:Cigarette smoke induced lung fibrosis: 08 November 2024 by Eweitz ‎(Modified title)
  31. (diff) . . Homo sapiens:Dravet syndrome: 07 November 2024 by Fehrhart ‎(Added SNTA1 )
  32. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(updated phospho sites)
  33. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(layout)
  34. (diff) . . :: 06 November 2024 by Khanspers ‎(Author request: content was: ' :: 06 November 2024 by Khanspers ‎(Author request: content was: ' )
  35. (diff) . . :: 06 November 2024 by Khanspers ‎(Author request: content was: ' Pulmonary emb)
  36. (diff) . . :: 06 November 2024 by Khanspers ‎(Author request: content was: ' )
  37. (diff) . . Homo sapiens:Cigarette smoke induced lung fibrosis: 06 November 2024 by Marvin M2 ‎(added literature references and visual cleanup)
  38. (diff) . . Homo sapiens:Cigarette smoke induced lung fibrosis: 06 November 2024 by Marvin M2 ‎(added KE IDs)
  39. (diff) . . Homo sapiens:Cigarette smoke induced lung fibrosis: 06 November 2024 by Marvin M2 ‎(Ontology Term : 'pulmonary fibrosis' added !)
  40. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(Ontology Term : 'altered growth factor signaling pathway' added !)
  41. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(Ontology Term : 'leukemia pathway' added !)
  42. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(board width)
  43. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(board width)
  44. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(board hieght)
  45. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(board height)
  46. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(layout)
  47. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(Modified description)
  48. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(Modified description)
  49. (diff) . . Homo sapiens:Effect of dasatinib on the BCR-ABL signaling pathway: 06 November 2024 by Khanspers ‎(New pathway)

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)